{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:46:41Z","timestamp":1792043201092,"version":"4.4.0"},"reference-count":47,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"NIHR Exeter Biomedical Research Centre","award":["NIHR203320 (HH)"],"award-info":[{"award-number":["NIHR203320 (HH)"]}]},{"name":"UK Cancer Genetics Group","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2024,3,9]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Mismatch repair deficiency (dMMR) is a characteristic feature of cancers linked to Lynch syndrome. However, in most cases, it results from sporadic somatic events rather than hereditary factors. The term \u2018Lynch-like syndrome\u2019 (LLS) has been used to guide colorectal cancer surveillance for relatives of individuals with a dMMR tumour when somatic and germline genomic testing is uninformative. As the assessment of mismatch repair through immunohistochemistry and\/or microsatellite instability is increasingly applied across various tumour types for treatment planning, dMMR is increasingly detected in tumours where suspicion of hereditary aetiology is low. Our objective was to establish current practices and develop national guidance for investigating, and managing relatives of, patients with cancers demonstrating unexplained dMMR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was achieved through a virtual consensus meeting involving key stakeholders from the UK, through premeeting surveys, structured discussions and in-meeting polling to formulate best practice guidance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified variability in the availability of diagnostic technologies across specialist centres. It was agreed that equitable access to baseline testing is required, acknowledging the need for a pragmatic approach to investigating dMMR cancers not traditionally associated with Lynch syndrome. Factors such as family history, age, tumour type, protein loss pattern and extent of the investigation were deemed crucial in guiding family management. The term \u2018unexplained dMMR\u2019 was recommended over LLS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Decisions regarding investigations and future cancer risk management in patients and relatives should be nuanced, considering factors like clinical suspicion of hereditary predisposition to allocate limited resources efficiently and avoid unnecessary investigations in low-suspicion families.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmg-2024-109886","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T13:26:32Z","timestamp":1711459592000},"page":"707-715","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Extent of investigation and management of cases of \u2018unexplained\u2019 mismatch repair deficiency (u-dMMR): a UK Cancer Genetics Group consensus"],"prefix":"10.1136","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-9216","authenticated-orcid":false,"given":"Terri Patricia","family":"McVeigh","sequence":"first","affiliation":[{"name":"Cancer Genetics Unit, Royal Marsden Hospital NHS Trust, London, UK"},{"name":"The Institute of Cancer Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J","family":"Monahan","sequence":"additional","affiliation":[{"name":"St Mark's Academic Institute Polyposis Registry, Harrow, UK"},{"name":"Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Christopher","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"},{"name":"Department of Medical Genetics, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"West","sequence":"additional","affiliation":[{"name":"University of Leeds, Leeds, UK"},{"name":"Department of Histopathology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Scott","sequence":"additional","affiliation":[{"name":"Familial Cancer Clinic, Department of Gynaecology, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Murray","sequence":"additional","affiliation":[{"name":"Southeast Scotland Genetics Service, Western General Hospital, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3303-8713","authenticated-orcid":false,"given":"Helen","family":"Hanson","sequence":"additional","affiliation":[{"name":"Peninsula Regional Genetics Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK"},{"name":"Faculty of Health and Life Sciences, University of Exeter Medical School, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"2025100510522088000_61.7.707.1","article-title":"Unexplained mismatch repair deficiency: case closed","volume":"4","author":"Eikenboom","year":"2023","journal-title":"HGG Adv"},{"key":"2025100510522088000_61.7.707.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2906-9"},{"key":"2025100510522088000_61.7.707.3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23319-1","article-title":"A scoping review and meta-analysis on the prevalence of Pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours","volume":"12","author":"Kang","year":"2022","journal-title":"Sci Rep"},{"key":"2025100510522088000_61.7.707.4","doi-asserted-by":"crossref","unstructured":"Bonneville R , Krook MA , Kautto EA , et al . Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol 2017;2017. doi:10.1200\/PO.17.00073","DOI":"10.1200\/PO.17.00073"},{"key":"2025100510522088000_61.7.707.5","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0046"},{"key":"2025100510522088000_61.7.707.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733"},{"key":"2025100510522088000_61.7.707.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003263","article-title":"The proportion of endometrial tumours associated with Lynch syndrome (PETALS): a prospective cross-sectional study","volume":"17","author":"Ryan","year":"2020","journal-title":"PLoS Med"},{"key":"2025100510522088000_61.7.707.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.064"},{"key":"2025100510522088000_61.7.707.9","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2011.277"},{"key":"2025100510522088000_61.7.707.10","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2012.91"},{"key":"2025100510522088000_61.7.707.11","unstructured":"NICE . National Institute for Health and Care Excellence Guidance: molecular testing strategies for Lynch syndrome in people with colorectal cancer. Diagnostics guidance [DG27]; 2017."},{"key":"2025100510522088000_61.7.707.12","unstructured":"NICE . National Institute for Health and Care Excellence Guidance: testing strategies for Lynch syndrome in people with endometrial cancer. Diagnostics guidance [DG42]; 2020."},{"key":"2025100510522088000_61.7.707.13","doi-asserted-by":"publisher","DOI":"10.1111\/his.14390"},{"key":"2025100510522088000_61.7.707.14","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-013-9671-6"},{"key":"2025100510522088000_61.7.707.15","unstructured":"NHS England . National Genomic test directory - rare and inherited disease eligibility criteria; 2024. 6."},{"key":"2025100510522088000_61.7.707.16","unstructured":"NHS Scotland . Scottish strategic network for genomic medicine genomic test directory rare & inherited disease; 2023. 2."},{"key":"2025100510522088000_61.7.707.17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030467","article-title":"Diagnosis of Lynch syndrome and strategies to distinguish Lynch-related tumors from sporadic MSI\/dMMR tumors","volume":"13","author":"Leclerc","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025100510522088000_61.7.707.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2020.12.003"},{"key":"2025100510522088000_61.7.707.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.04.021"},{"key":"2025100510522088000_61.7.707.20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.08.041"},{"key":"2025100510522088000_61.7.707.21","doi-asserted-by":"crossref","unstructured":"Walker R , Mahmood K , Joo JE , et al . A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome. medRxiv 2023. doi:10.1101\/2023.02.27.23285541","DOI":"10.1186\/s12967-023-04143-1"},{"key":"2025100510522088000_61.7.707.22","unstructured":"Arends M , Ibrahim M , Happerfield L , et al . Interpretation of immunohistochemical analysis of mismatch repair (MMR) protein expression in tissue sections for investigation of suspected Lynch \/ hereditary non-polyposis colorectal cancer (HNPCC) syndrome. NEQAS ICC & ISH recommendations; 2008."},{"key":"2025100510522088000_61.7.707.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2017.01.011"},{"key":"2025100510522088000_61.7.707.24","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319915"},{"key":"2025100510522088000_61.7.707.25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051115","article-title":"Lynch-like syndrome: potential mechanisms and management","volume":"14","author":"Mart\u00ednez-Roca","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025100510522088000_61.7.707.26","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2018-105698"},{"key":"2025100510522088000_61.7.707.27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.044"},{"key":"2025100510522088000_61.7.707.28","unstructured":"UKCGG information and education: National cancer Genetics MDT. 2023. Available: https:\/\/www.ukcgg.org\/information-education [Accessed 09 Jan 2024]."},{"key":"2025100510522088000_61.7.707.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.12.002"},{"key":"2025100510522088000_61.7.707.30","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2023-109440"},{"key":"2025100510522088000_61.7.707.31","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18682"},{"key":"2025100510522088000_61.7.707.32","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18675"},{"key":"2025100510522088000_61.7.707.33","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2022-108898"},{"key":"2025100510522088000_61.7.707.34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jmedgenet-2020-106876","article-title":"UKCGG consensus group guidelines for the management of patients with constitutional TP53 pathogenic variants","volume":"58","author":"Hanson","year":"2020","journal-title":"J Med Genet"},{"key":"2025100510522088000_61.7.707.35","unstructured":"Lokuhetty D , White VA , Watanabe R , et al . Genetic tumour syndromes of the digestive system, in digestive system tumours. Lyon International Agency for Research on Cancer; 2019. 511."},{"key":"2025100510522088000_61.7.707.36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.6120"},{"key":"2025100510522088000_61.7.707.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.08.009"},{"key":"2025100510522088000_61.7.707.38","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1546"},{"key":"2025100510522088000_61.7.707.39","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-4-273"},{"key":"2025100510522088000_61.7.707.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjonc-2023-000124","article-title":"The English national Lynch syndrome transformation project: an NHS Genomic medicine service alliance (GMSA) programme","volume":"2","author":"Monahan","year":"2023","journal-title":"Bmjonc"},{"key":"2025100510522088000_61.7.707.41","doi-asserted-by":"publisher","DOI":"10.1111\/codi.16707"},{"key":"2025100510522088000_61.7.707.42","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2022-108800"},{"key":"2025100510522088000_61.7.707.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70510-X"},{"key":"2025100510522088000_61.7.707.44","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh034"},{"key":"2025100510522088000_61.7.707.45","unstructured":"Singh N , Wong R , Tchrakian N , et al . Interpretation and reporting terminology for mismatch repair protein immunohistochemistry in endometrial cancer. The British Association of Gynaecological Pathologists; 2020."},{"key":"2025100510522088000_61.7.707.46","unstructured":"Garrett A , Allen S , Loong L , et al . CanVig-UK consensus specification for cancer susceptibility genes (CSGs) of ACGS best practice guidelines for variant classification; 2022."},{"key":"2025100510522088000_61.7.707.47","unstructured":"Ellard S , Baple EL , Callaway A , et al . ACGS best practice guidelines for variant classification in rare disease 2020; 2020."}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2024-109886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:52:29Z","timestamp":1759686749000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2024-109886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,6,20]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/jmg-2024-109886"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2024-109886","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}